[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2024,74(3):229-263. [2] Guo H L, Zheng X, Cheng M Q, et al. Contrast-enhanced ultrasound for differentiation between poorly differentiated hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Ultrasound Med,2022,41(5):1213-1225. [3] Dong Y, Chen S, Moller K, et al. Applications of dynamic contrast-enhanced ultrasound indifferential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic liver. Ultrasound Med Biol,2023,49(8):1780-1788. [4] Vidili G, Arru M, Solinas G, et al. Contrast-enhanced ultrasoundliver imaging reporting and data system: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. World J Gastroenterol,2022,28(27):3488-3502. [5] Wang X, Liang P, Yu J, et al. Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma. Br J Radiol,2022,95(1133):20211379. [6] Zhu M R, Zhao C K, Sun Y K, et al. Subtype prediction of intrahepatic cholangiocarcinoma using dynamic contrast-enhanced ultrasound. Insights Imaging,2024,15(1):119. [7] Chang G Y, Fetzer D T, Porembka M R. Contrast-enhanced intraoperative ultrasound of the liver. Surg Oncol Clin N Am,2022,31(4):707-719. [8] Liu Z, Luo C, Chen X, et al. Noninvasive prediction of perineural invasion in intrahepaticcholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study. Int J Surg,2024,110(2):1039-1051. [9] Ainora M E, Cerrito L, Liguori A, et al. Multiparametricdynamic ultrasound approach for differential diagnosis of primary liver tumors. Int J Mol Sci,2023,24(10):8548. [10] Schellhaas B, Jesper D, Strobel D. Contrast-enhanced ultrasound pattern of hepatocellular carcinoma in noncirrhotic liver-results from the prospective multicentre DEGUM CEUS HCC study. Eur J Gastroenterol Hepatol,2023,35(3):313-319. [11] Su L Y, Xu M, Chen Y L, et al. Ultrasomics in liver cancer: Developing a radiomics modelfor differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma using contrast-enhanced ultrasound. World J Radiol,2024,16(7):247-255. [12] 刘春蕊,薛海燕,刘晗,等. 基于临床和超声特征的术前诊断肝内胆管癌列线图的构建与评估. 中华肝胆外科杂志,2024,30(5):354-359. [13] 刘春蕊,薛海燕,刘晗,等. 基于临床、常规超声及CEUS的列线图术前鉴别肝细胞癌和肝内胆管癌. 中华超声影像学杂志,2024,33(5):369-377. [14] Faccia M, Garcovich M, Ainora M E, et al. Contrast-enhancedultrasound for monitoring treatment response in different stages of hepatocellular carcinoma. Cancers (Basel),2022,14(3):481. [15] Mei Q, Yu M, Chen Q. Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (</= 2 cm). World J Clin Cases,2022,10(24):8525-8534. [16] Zhou H, Zhang C, Du L, et al. Contrast-enhanced ultrasound liver imaging reporting and data system in diagnosing hepatocellular carcinoma: diagnostic performance and interobserver agreement. Ultraschall Med,2022,43(1):64-71. [17] Bartolotta T V, Randazzo A, Bruno E, et al. Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography. World J Radiol,2022,14(4):70-81. [18] Cai W J, Ying M, Zheng R Q, et al. Contrast-enhanced ultrasound liver imaging reporting and data system in hepatocellular carcinoma </=5 cm: biological characteristics and patient outcomes. Liver Cancer,2023,12(4):356-371. [19] Fraquelli M, Nadarevic T, Colli A, et al. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev,2022,9(9):D13483. [20] Wan P, Xue H, Liu C, et al. Transport-based anatomical-functional metric learning for liver tumor recognition using dual-view dynamic CEUS imaging. IEEE Trans Biomed Eng,2023,70(3):1012-1023. [21] Wang L F, Guan X, Shen Y T, et al. A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Abdom Radiol (NY),2024,49(2):458-470. [22] Xu Y, Chen K, Zhang Q, et al. Ultrasound findings of hepatic epithelioid hemangioendothelioma: comparison with other malignant hepatic tumors. Abdom Radiol (NY),2024,49(3):762-773. [23] Dong Y, Wang W P, Lee W J, et al. Contrast-enhanced ultrasound features of histopathologically proven hepatocellular carcinoma in the non-cirrhotic liver: a multicenter study. Ultrasound Med Biol,2022,48(9):1797-1805. [24] Wang S, Yao J, Li K, et al. Nomogram based on sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study. Abdom Radiol (NY),2023,48(10):3101-3113. [25] Wu Y, Xia C, Chen J, et al. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma:a meta-analysis. Abdom Radiol (NY),2024,49(1):34-48. [26] Gismondo V G, Lico M, Teti A, et al. Diagnosis of intrahepatic cholangiocarcinoma with CEUS. J Ultrason,2024,24(96):20240005. |